We can help client design and carry out aspects of Risk Management and Risk Minimisation plans, as part of wider pharmacovigilance measures advocated by competent authorities, such as MHRA, EMA and FDA
All services can be conducted in any EU language for EMA projects. Services in this area include:
Development of patient education materials to support a Risk Management or Minimisation Plan.
Special communication programmes and educational material for healthcare professionals and patients as part of RMP communication plans.
User evaluation studies to measure the effectiveness of communication plans for users (healthcare professionals and patients alike).
Join us in shaping the future of healthcare
Contact us if you want to find out how we can help you with your project, if you wish to become part of our network of in-country partners or if you want to take part in one of our studies.
